Sign in
Active, not recruitingNo phase

An Observational Study of Individuals With Isolated Dystonia

Key facts

Who runs it
Vima Therapeutics
Where
Albuquerque, Aliso Viejo, Atlanta, Boca Raton, Charleston, Chicago, Commack, Dallas, Englewood, Farmington Hills, Gainesville, Georgetown, Houston, Kirkland, Los Angeles, Memphis, Miami, Nashville, New York, Olney, Orlando, Palo Alto, Philadelphia, Portland, Richmond, Scottsdale, Spokane, and Sun City, United StatesSee the 29 sites
Trial code
Status
Active, not recruiting
People taking part
200 people, planned
Started
17 Jun 2025
Expected to end
Nov 2026
Type of study
Observational
Record updated
13 November 2026

Who can take part

Age
12 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • The participant is willing to sign an informed consent form indicating that he/she understands the purpose of the study; understands and can perform, complete, and comply with all the assessments that are required during the study; and is willing to participate in the study
  • The participant is a male or female between 12 and 65 years of age (inclusive)
  • The participant has a clinical diagnosis of isolated (or primary) dystonia for at least one year prior to Visit 1 and meets the study definition of segmental/multifocal or generalized dystonia at Visit 1

Who cannot take part

  • The participant has had myotomy or denervation surgery in any affected muscles (e.g., peripheral denervation and/or spinal cord stimulation)
  • The participant has undergone deep brain stimulation (DBS) surgery (even if implant deactivated)
  • The participant has a history of any psychiatric or cognitive impairment disorder that, in the opinion of the investigator, may interfere with study conduct
  • The participant has marked limitation on passive range of motion that suggests contractures or other structural abnormality (e.g., cervical contractures or cervical spine syndrome)
  • The participant has any significant ongoing disease, disorder, laboratory abnormalities, alcohol or illicit drug abuse or dependence, environmental factor, or any ongoing or history of any medical or surgical condition that in the judgment of the investigator, in consultation with the medical monitor and/or sponsor's designee, might jeopardize the participant's safety, impact the scientific objectives of the clinical study, or interfere with participation in the clinical study
  • The participant has a diagnosis of focal dystonia at Visit 1
  • The participant has a diagnosis of dopa-responsive dystonia, secondary dystonia, or psychogenic/functional dystonia

Where in United States

  • Albuquerque, New MexicoHospital not named in the registry
  • Aliso Viejo, CaliforniaHospital not named in the registry
  • Atlanta, GeorgiaHospital not named in the registry
  • Boca Raton, FloridaHospital not named in the registry
  • Charleston, South CarolinaHospital not named in the registry
  • Chicago, IllinoisHospital not named in the registry
  • Commack, New YorkHospital not named in the registry
  • Dallas, TexasHospital not named in the registry
  • Englewood, ColoradoHospital not named in the registry
  • Farmington Hills, MichiganHospital not named in the registry
  • Gainesville, FloridaHospital not named in the registry
  • Georgetown, TexasHospital not named in the registry
  • Houston, TexasHospital not named in the registry
  • Kirkland, WashingtonHospital not named in the registry
  • Los Angeles, CaliforniaHospital not named in the registry
  • Memphis, TennesseeHospital not named in the registry
  • Miami, FloridaHospital not named in the registry
  • Nashville, TennesseeHospital not named in the registry
  • New YorkHospital not named in the registry
  • New YorkHospital not named in the registry
  • Olney, MarylandHospital not named in the registry
  • Orlando, FloridaHospital not named in the registry
  • Palo Alto, CaliforniaHospital not named in the registry
  • Philadelphia, PennsylvaniaHospital not named in the registry
  • Portland, OregonHospital not named in the registry
  • Richmond, VirginiaHospital not named in the registry
  • Scottsdale, ArizonaHospital not named in the registry
  • Spokane, WashingtonHospital not named in the registry
  • Sun City, ArizonaHospital not named in the registry

About the trial

What the trial wants to find out

This is an observational study in individuals with isolated (or primary) dystonia that involves more than one body region. The purpose of the study is to collect detailed information to help your physician and other researchers understand how dystonia impacts your and other patients' lives and how the disease changes over time. The study may also help researchers better understand the clinical scales that are commonly used to evaluate dystonia symptoms and how they affect various areas of life such as well-being, pain, relationships and social interactions, and progress over time. Because this is an observational study, you will not receive any interventional treatment in the study.

The group in the trial

  • Isolated (or Primary) Dystonia Cohort

    This is a single-arm noninterventional, prospective observational study enrolling up to 200 male and female participants (ages 12 - 65 years, inclusive) that have been diagnosed with isolated dystonia for at least one year prior to the first study visit. Candidates with focal dystonia (i.e., only one body part affected) are not eligible for participation. However, the Investigator may query such patients to determine if symptoms have spread to other regions, which may allow them to be eligible for study entry.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
13 November 2026